Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2018-07
  • Milk-Derived Vesicle Uptake Mechanisms in ISC Organoid Model

    2026-05-02

    Comprehensive Dissection of Milk-Derived Extracellular Vesicle Uptake in Intestinal Stem Cell Organoids

    Study Background and Research Question

    Milk-derived extracellular vesicles (MEV), nanoscale bioactive particles present in breast milk, are increasingly recognized for their regulatory effects on intestinal physiology and potential as drug delivery vehicles (reference). While previous studies explored MEV bioactivity using immortalized cell lines, such models lack the cellular complexity and regional specialization of in vivo intestinal tissue. This gap has limited our understanding of MEV’s mechanisms of entry and influence on intestinal stem cell (ISC) biology. The reference study addresses a crucial research question: How do MEV interact with physiologically relevant ISC-based models, and what are the cellular mechanisms governing their uptake and functional effects?

    Key Innovation from the Reference Study

    The principal innovation lies in the establishment and comparative analysis of three advanced porcine ISC-based organoid models: basal-out organoids, organoid monolayers, and apical-out organoids. These models recapitulate the regional architecture and epithelial polarity of the small intestine and colon, thus providing a superior platform to dissect MEV uptake and function in a context closely resembling in vivo conditions. The study uniquely demonstrates that MEV are internalized via the apical surface of intestinal epithelial cells (IEC), and that this uptake is model- and region-specific. Furthermore, the research elucidates how MEV modulate the expression of genes linked to ISC stemness and differentiation, offering novel insights into the functional consequences of vesicle trafficking in the gut (reference).

    Methods and Experimental Design Insights

    The investigators derived ISC-based organoids from the duodenum, jejunum, ileum, and colon of suckling piglets. These included:
    • Basal-out organoids: Conventional 3D spherical structures with basal polarity facing outward.
    • Organoid monolayers: Flattened epithelial sheets grown on permeable supports, enabling controlled apical and basolateral access.
    • Apical-out organoids: 3D spheroids with apical membrane exposed to the culture medium, facilitating direct study of luminal uptake mechanisms.
    MEV were isolated from pooled porcine milk using differential ultracentrifugation, minimizing freeze-thaw cycles to preserve vesicle integrity. The uptake of fluorescently labeled MEV was tracked in each organoid model, and the impact on ISC gene expression was assessed using quantitative PCR and immunostaining. Critically, mechanistic experiments employed small-molecule inhibitors targeting various endocytic pathways to pinpoint the routes of MEV entry into IEC (reference).

    Protocol Parameters

    • Organoid culture duration | 7–10 days | All ISC-based models | Sufficient to establish crypt-villus or sheet-like architecture and cell differentiation | paper
    • MEV storage temperature | 4°C, <24 h | Vesicle isolation | Minimizes freeze-thaw damage and preserves functional cargo | paper
    • Endocytosis inhibitor application | Variable (preincubation before MEV addition, typically 30–60 min) | Uptake mechanism assays | Ensures specific blockade of intended trafficking pathways | workflow_recommendation
    • Gene expression analysis | qPCR, immunostaining | All models | Quantitative insight into ISC stemness and differentiation | paper

    Core Findings and Why They Matter

    The study reveals several key discoveries:
    • Model- and Region-Specific Uptake: MEV are internalized efficiently by organoid monolayers and apical-out organoids, but not by basal-out organoids, highlighting the importance of apical membrane exposure in vesicle trafficking (reference).
    • Functional Modulation: Exposure to MEV increases the expression of genes associated with stemness and differentiation in colon-derived ISC, implicating MEV as modulators of epithelial renewal and maturation.
    • Endocytosis-Dependent Mechanism: Uptake of MEV is significantly suppressed by endocytosis inhibitors, confirming that internalization is an active, dynamin- and energy-dependent process rather than passive diffusion.
    • Physiological Validation: The ISC-derived models display correct epithelial polarity, diversity of cell types (enterocyte, goblet, Paneth, enteroendocrine cells), and functional barrier and nutrient uptake properties, mirroring the in vivo intestine.
    Collectively, these findings underscore the value of advanced ISC organoid systems for mechanistic studies of extracellular vesicle trafficking and functional impact, surpassing the limitations of immortalized cell lines.

    Comparison with Existing Internal Articles

    The reference study’s approach and findings are highly synergistic with several internal resources: These complementary resources collectively frame a robust workflow for membrane remodeling studies and intracellular trafficking research in organoid models.

    Limitations and Transferability

    Despite its advances, the study has several limitations. The use of porcine models, while physiologically relevant for translational research and agriculture, may not fully recapitulate human ISC biology or MEV responses. The organoid systems, although complex, cannot model immune cell–epithelial interactions or the full spectrum of gut microbiota effects. Additionally, the reliance on pharmacological inhibitors, while insightful, can introduce off-target effects; genetic approaches may provide further specificity in future work. Finally, long-term effects and in vivo confirmation of MEV-driven ISC modulation remain to be fully established (reference).

    Research Support Resources

    For researchers seeking to reproduce or extend these workflows, precise inhibition of endocytosis and membrane trafficking is essential. MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide, SKU B7620) from APExBIO is a potent and selective dynamin GTPase activity inhibitor, widely used as an endocytosis research compound. Its application allows for mechanistic dissection of vesicle uptake in ISC organoid models, as highlighted in both the reference study and recent internal articles. MitMAB exhibits excellent solubility and stability properties (source: product_spec), and is intended strictly for research use. For detailed workflow guidance, see related internal resources above.